Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/7045
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPecorelli, S.-
dc.contributor.authorWagenaar, H.C.-
dc.contributor.authorVergote, I.B.-
dc.contributor.authorCURRAN, Desmond-
dc.contributor.authorBeex, L.V.A.-
dc.contributor.authorWiltshaw, E.-
dc.contributor.authorVermorken, J.B.-
dc.date.accessioned2007-12-20T16:12:32Z-
dc.date.available2007-12-20T16:12:32Z-
dc.date.issued1999-
dc.identifier.citationEuropean journal of cancer, 35(9). p. 1331-1337-
dc.identifier.issn0959-8049-
dc.identifier.urihttp://hdl.handle.net/1942/7045-
dc.language.isoen-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.titleCisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa (-Theca) cell tumours of the ovray: an EORTC Gynaecological Cancer Cooperative Group Study-
dc.typeJournal Contribution-
dc.identifier.epage1337-
dc.identifier.issue9-
dc.identifier.spage1331-
dc.identifier.volume35-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1016/S0959-8049(99)00142-2-
dc.identifier.isi000083602800026-
item.fulltextNo Fulltext-
item.contributorPecorelli, S.-
item.contributorWagenaar, H.C.-
item.contributorVergote, I.B.-
item.contributorCURRAN, Desmond-
item.contributorBeex, L.V.A.-
item.contributorWiltshaw, E.-
item.contributorVermorken, J.B.-
item.fullcitationPecorelli, S.; Wagenaar, H.C.; Vergote, I.B.; CURRAN, Desmond; Beex, L.V.A.; Wiltshaw, E. & Vermorken, J.B. (1999) Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa (-Theca) cell tumours of the ovray: an EORTC Gynaecological Cancer Cooperative Group Study. In: European journal of cancer, 35(9). p. 1331-1337.-
item.accessRightsClosed Access-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

58
checked on Dec 11, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.